2018•Annals of the Rheumatic DiseasesOpen access

AB1470-HPR Beliefs and satisfaction with golimumab as second anti tnf-alpha of patients with spondyloarthritis. go-beyond

Xavier Juanola, C.M. González Fernández, Sara García, J. Rodríguez-Hereida, Javier Bachiller‐Corral, María Martín-López, M. Retuerto Guerrero, J M Santos, Noelia Álvarez-Rivas, César Egües Dubuc, Ignacio Villa-Blanco, Ana María Láiz, J.V. Tovar Beltrán, Emma Beltrán, Enrique Raya, Rosario Ibáñez Bosch, Javier Manero, Jordi Pons Dolset, Blanca García Magallón, Yvonne Mestre, S. Fernández, Marta E. G. Mosquera, Luis Cea‐Calvo, Juan José Alegre Sancho

Open full text 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Golimumab, Medicine, Psoriatic arthritis, Internal medicine, Physical therapy, Rheumatology, Likert scale, Etanercept

Related papers

Back to paper searchBrowse research topicsOriginal source
AB1470-HPR Beliefs and satisfaction with golimumab as second anti tnf-alpha of patients with spondyloarthritis. go-beyond — Research Paper | ScholarLens